BPCR — Biopharma Credit Cashflow Statement
0.000.00%
Last trade - 00:00
- $1.06bn
- $969.71m
- $135.73m
- 68
- 79
- 71
- 87
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 132 | 58.1 | 96.4 | 184 | 123 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | 132 | 58.1 | 96.4 | 184 | 123 |
Other Investing Cash Flow Items | -100 | -47.5 | -94.8 | 48.2 | -1.66 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -100 | -47.5 | -94.8 | 48.2 | -1.66 |
Financing Cash Flow Items | 0 | — | — | — | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | -98.1 | -114 | -100 | -207 | -107 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -66.9 | -103 | -98.6 | 25.8 | 14.5 |